EP3911354

AAV-miðluð genameðhöndlun til að laga Otoferlin-genið

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    20.1.2020
  • EP published:
    19.7.2023
  • EP application number:
    20701951.4
  • Max expiry date:
    19.1.2040
  • Expiry date:
    19.1.2027
  • Next due date:
    31.1.2027
  • Title in English:
    AAV-MEDIATED GENE THERAPY RESTORING THE OTOFERLIN GENE
  • Language of the patent:
    English

Timeline

Today
20.1.2020EP application
19.7.2023EP Publication
16.10.2023Translation submitted
15.11.2023Registration published
19.1.2027Expires

Owner

  • Name:
    Institut Pasteur
  • Address:
    25-28, rue du Docteur Roux, 75015 Paris, FR
  • Name:
    CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
  • Address:
    3, rue Michel-Ange, 75016 Paris, FR
  • Name:
    Institut National de la Santé et de la Recherche Médicale (INSERM)
  • Address:
    101 rue Tolbiac, 75013 Paris, FR

Inventor

  • Name:
    SAFIEDDINE, Saaid
  • Address:
    75012 Paris, FR
  • Name:
    PETIT, Christine
  • Address:
    75012 Paris, FR

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    19305071
  • Date:
    18.1.2019
  • Country:
    EP

Classification

  • Categories:
    A61K 38/16, A61K 48/00, C07K 14/00, C12N 15/86, A61P 27/16

Annual fees

Number

Paid

Expires

Payer

Number: 5

Paid: 20.12.2023

Expires: 19.1.2025

Payer: Acumass

Number: 6

Paid: 13.1.2025

Expires: 19.1.2026

Payer: G.H. Sigurgeirsson ehf.

Number: 7

Paid: 12.1.2026

Expires: 19.1.2027

Payer: G.H. Sigurgeirsson ehf.

Upload documents